| abstract |
The invention concerns an active ingredient consisting of several polylysine compounds, said polylysine compounds consisting of at least one small molecule conjugated to a polylysine, said active ingredient comprising at least the following polylysine compounds: - coenzyme Q10-polylysine, - retinoic acid-polylysine, - cysteine-polylysine, - taurine-polylysine, - glutathione-polylysine, for use in humans or animals, in the prevention of strokes and/or in the treatment of the inflammatory phase that follows a stroke. |